"Neuroscience, Clinical Trials, and the Future of Psychedelic Medicine” with Joshua Siegel, MD, PhD episode artwork

EPISODE · Aug 18, 2025 · 55 MIN

"Neuroscience, Clinical Trials, and the Future of Psychedelic Medicine” with Joshua Siegel, MD, PhD

from The Gold Standard with Mark S. Gold, MD · host Hatherleigh Behavioral Health

This comprehensive dialogue between Dr. Mark Gold and Dr. Joshua Siegel highlights the remarkable scientific advancements and ongoing challenges in the field of psychedelic medicine. By integrating deep neuroscience with clinical rigor and ethical mindfulness, researchers are poised to transform mental health treatment paradigms. The interview underscores that while psychedelics hold tremendous promise, their safe, effective, and equitable integration into clinical practice depends on maintaining meticulous scientific standards, embracing interdisciplinary perspectives, and thoughtfully addressing societal and regulatory complexities.

Episode metadata supplied by the publisher feed · Published Aug 18, 2025

Embed this episode

Ready to play

"Neuroscience, Clinical Trials, and the Future of Psychedelic Medicine” with Joshua Siegel, MD, PhD

0:00 55:17

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Gold Standard with Mark S. Gold, MD?

This episode is 55 minutes long.

When was this The Gold Standard with Mark S. Gold, MD episode published?

This episode was published on August 18, 2025.

Can I download this The Gold Standard with Mark S. Gold, MD episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!